EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Epigenetic regulation in lung cancer

Shahin Ramazi, Maedeh Dadzadi, Zahra Sahafnejad, Abdollah Allahverdi

MedComm · 2023-12 · 4 (6)

DOI: 10.1002/mco2.401 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 26.10.2023. Verfasst von Shahin Ramazi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics Faculty of Biological Sciences Tarbiat Modares University Tehran Iran. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 380 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iran National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is indeed a major cause of cancer‐related deaths worldwide. The development of tumors involves a complex interplay of genetic, epigenetic, and environmental factors. Epigenetic mechanisms, including DNA methylation (DNAm), histone modifications, and microRNA expression, play a crucial role in this process. Changes in DNAm patterns can lead to the silencing of important genes involved in cellular functions, contributing to the development and progression of lung cancer. MicroRNAs and exosomes have also emerged as reliable biomarkers for lung cancer. They can provide valuable information about early diagnosis and treatment assessment. In particular, abnormal hypermethylation of gene promoters and its effects on tumorigenesis, as well as its roles in the Wnt signaling pathway, have been extensively studied. Epigenetic drugs have shown promise in the treatment of lung cancer. These drugs target the aberrant epigenetic modifications that are involved in the development and progression of the disease. Several factors have been identified as drug targets in non‐small cell lung cancer. Recently, combination therapy has been discussed as a successful strategy for overcoming drug resistance. Overall, understanding the role of epigenetic mechanisms and their targeting through drugs is an important area of research in lung cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

DNA methylationWnt signaling pathwayaberrant hypermethylationepigenetic markerlung cancertumor suppressor genes

Autor:innen und Institutionen

  • Department of Biophysics Faculty of Biological Sciences Tarbiat Modares University Tehran Iran.
  • Department of Biotechnology Faculty of Advanced Science and Technology Tehran Medical Sciences Islamic Azad University Tehran Iran.

Förderung

  • Iran National Science Foundation

Zitieren

APA

Ramazi, S., Dadzadi, M., Sahafnejad, Z., & Allahverdi, A. (2023). Epigenetic regulation in lung cancer. MedComm, 4(6). https://doi.org/10.1002/mco2.401

Vancouver

Ramazi S, Dadzadi M, Sahafnejad Z, Allahverdi A. Epigenetic regulation in lung cancer. MedComm. 2023;4(6). doi:10.1002/mco2.401

BibTeX
@article{Ramazi2023,
  author = {Ramazi, Shahin and Dadzadi, Maedeh and Sahafnejad, Zahra and Allahverdi, Abdollah},
  title = {Epigenetic regulation in lung cancer},
  journal = {MedComm},
  year = {2023},
  volume = {4},
  number = {6},
  doi = {10.1002/mco2.401}
}
Kostenlos starten →